108Accesses
This is a preview of subscription content,log in via an institution to check access.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price includes VAT (Japan)
Instant access to the full article PDF.
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association, 2000
Curran MP. Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients. Pediatr Drugs 2011; 13 (3): 197–204
Bristol-Myers Squibb. Abilify® (aripiprazole) tablets: US prescribing information [online]. Available from URL:http://www.abilify.com/pds/pi.aspx [Accessed 2011 Jan 10]
Findling RL, Kauffman R, Sallee FR, et al. An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. J Child Adolesc Psychopharmacol 2009; 19 (4): 431–9
Robb AS, Andersson C, Bellocchio EE, et al. Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6–17 years old): results from a pooled analysis of 2 studies. Prim Care Companion CNS Disord 2011; 13 (1). pii: PCC. 10m01088
Malone RP, Waheed A. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs 2009; 69 (5): 535–48
Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009 Dec; 124 (6): 1533–40
Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009 Nov; 48 (11): 1110–9
Bristol-Myers Squibb. Final study report for study CN138180: a 52-week open-label multicenter study of the safety and tolerability of aripiprazole flexibly doses in the treatment of children and adolescents with austistic disorder [online]. Available from URL:http://www.clinicalstudyresults.org/documents/companystudy_8998_2.pdf [Accessed 2011 Jan 9]
Author information
Authors and Affiliations
Adis, a Wolters Kluwer Business, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
Monique P. Curran
- Monique P. Curran
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toMonique P. Curran.
Additional information
Adapted and reproduced from the original article published inPediatric Drugs 2011; 13 (3): 197-204.
Rights and permissions
About this article
Cite this article
Curran, M.P. Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Paediatric Patients.CNS Drugs25, 801–802 (2011). https://doi.org/10.2165/11208280-000000000-00000
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative